CBD Global Sciences Inc., is pleased to announce that the Company has received purchase orders from multiple vendors for its newly launched CBD infused gummy line. The initial purchase orders are for in excess of 6.9 million units of our cannabidiol (CBD) edible format gummies.
The orders were received from several leading direct-to-consumer companies for distribution throughout the United States. The purchase orders were pursuant to ongoing private-label manufacturing and supply agreements and represent over USD$2 million in wholesale value.
Brad Wyatt, CEO & President of the Company, states, “We are pleased by the rapid acceptance of our product line extension”. Wyatt added, “The Gummy Format is becoming one of the most popular methods of CBD consumption and we look forward to continued sales growth in this product line”.